Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung

BACKGROUND: The histological classification of non-small cell lung cancer (NSCLC) is essential in determining new cancer-specific targeted therapies. However, the accurate typing of poorly differentiated is difficult, particularly for poorly differentiated squamous cell carcinoma and adenocarcinoma...

全面介紹

Na minha lista:
書目詳細資料
發表在:Transl Lung Cancer Res
Main Authors: Kai, Yuichiro, Amatya, Vishwa Jeet, Kushitani, Kei, Kambara, Takahiro, Suzuki, Rui, Fujii, Yutaro, Tsutani, Yasuhiro, Miyata, Yoshihiro, Okada, Morihito, Takeshima, Yukio
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2021
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947391/
https://ncbi.nlm.nih.gov/pubmed/33718020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-857
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍